Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FL56H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,176
Award facts
- Contract value 100% obligated
- $26,175.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $26,175.76 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pen injections on July 14, 2025, with completion scheduled for July 15, 2025. This non-competitive delivery order represents a firm fixed-price purchase of pharmaceutical products to support federal medical supply needs. The award was executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, providing a comprehensive global pharmaceutical support vehicle for military and federal healthcare systems.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal pharmaceutical supply chain, leveraging its prime IDV to deliver an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Zepbound, a diabetes and weight management medication, exemplifies the company's role in supplying specialty pharmaceuticals to support Defense Health Agency operations and other federal healthcare entities worldwide. The contract demonstrates the flexibility of the DLA's pharmaceutical acquisition strategy in procuring needed medications through established prime vendor relationships.
Quick answers
Who was awarded contract SPE2DB25FL56H?
SPE2DB25FL56H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FL56H worth?
The government has obligated $26,176 on SPE2DB25FL56H.
Is contract SPE2DB25FL56H an order under another contract?
Yes. SPE2DB25FL56H is a delivery order under SPE2DB20D2002, an indefinite delivery contract.
Was contract SPE2DB25FL56H competed?
The extent of competition for SPE2DB25FL56H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award